The Lancet Commission on diabetes: using data to transform diabetes care and patient lives

JCN Chan, LL Lim, NJ Wareham, JE Shaw, TJ Orchard… - The Lancet, 2020 - thelancet.com
Executive summary 2020 will go down in history as the year when the global community was
awakened to the fragility of human health and the interdependence of the ecosystem …

2022 National standards for diabetes self-management education and support

J Davis, AH Fischl, J Beck, L Browning… - The science of …, 2022 - journals.sagepub.com
Purpose: The National Standards for Diabetes Self-Management Education and Support
(DSMES) provide guidance and evidence-based, quality practice for all DSMES services …

Use of glucagon‐like peptide‐1 receptor agonists and bone fractures: A meta‐analysis of randomized clinical trials (胰高血糖素样肽‐1 受体激动剂的使用与骨折的关系 …

G Mabilleau, A Mieczkowska… - Journal of diabetes, 2014 - Wiley Online Library
摘要背景2 型糖尿病患者的骨折风险较高, 且不依赖于使用降糖药物. 此外, 降糖药物还可以直接
影响骨代谢. 最近, 已经发现使用二肽基肽酶‐4 抑制剂与较低的骨折发生率有关. 本meta …

Association of insulin resistance and elevated androgen levels with polycystic ovarian syndrome (PCOS): a review of literature

Y Xu, J Qiao - Journal of healthcare engineering, 2022 - Wiley Online Library
The polycystic ovary syndrome (PCOS) is the disease featured by elevated levels of
androgens, ovulatory dysfunction, and morphological abnormalities. At reproductive stage of …

Trends in diabetes treatment and control in US adults, 1999–2018

M Fang, D Wang, J Coresh… - New England Journal of …, 2021 - Mass Medical Soc
Background Documenting current trends in diabetes treatment and risk-factor control may
inform public health policy and planning. Methods We conducted a cross-sectional analysis …

Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study …

MJ Davies, DA D'Alessio, J Fradkin, WN Kernan… - Diabetes …, 2018 - pmc.ncbi.nlm.nih.gov
Abstract The American Diabetes Association and the European Association for the Study of
Diabetes convened a panel to update the prior position statements, published in 2012 and …

Pharmacological treatment of hyperglycemia in type 2 diabetes

SI Taylor, ZS Yazdi… - The Journal of clinical …, 2021 - Am Soc Clin Investig
Diabetes mellitus is a major public health problem, affecting about 10% of the population.
Pharmacotherapy aims to protect against microvascular complications, including blindness …

[HTML][HTML] Current trends in epidemiology of cardiovascular disease and cardiovascular risk management in type 2 diabetes

JS Yun, SH Ko - Metabolism, 2021 - Elsevier
With the advances in diabetes care, the trend of incident cardiovascular disease (CVD) in
patients with type 2 diabetes mellitus (T2DM) has been decreasing over past decades …

Oral semaglutide versus subcutaneous liraglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial

R Pratley, A Amod, ST Hoff, T Kadowaki, I Lingvay… - The Lancet, 2019 - thelancet.com
Summary Background Glucagon-like peptide-1 (GLP-1) receptor agonists are effective
treatments for type 2 diabetes, lowering glycated haemoglobin (HbA 1c) and weight, but are …

2017 National standards for diabetes self-management education and support

J Beck, DA Greenwood, L Blanton… - The Diabetes …, 2018 - journals.sagepub.com
Purpose The purpose of this study is to review the literature for Diabetes Self-Management
Education and Support (DSMES) to ensure the National Standards for DSMES (Standards) …